OVERVIEW
FOCUS AREAS
More than 40 years of strategic regulatory experience throughout the product lifecycle.
Regulatory Strategy
Agency Interactions
Early Access Pathways
European approval processes
Lorna provides expertise and mentorship to the European based team as we guide clients through the complex regulatory hurdles from early development through to approval and beyond.
Lorna has been Regulatory Advisor for numerous start up companies including overall strategic development, First in Human support through pre-IND, IND preparation and submission in the US and CTA approvals in the UK and Europe.
She also helps clients develop and implement their Phase II and III plans including advising on early access pathways, paediatric plans, orphan designations and preparation for Agency interactions and submissions.
Lorna has extensive experience of guiding through the complex regulatory process, especially in Europe including the mutual recognition, decentralised and centralised processes. She and her team advise on the strategy to respond to major objections, drive written responses and prepare for Oral Explanations, Scientific Advisory Group meetings and Referrals
Lorna can also review and assess regulatory departments experience and skills vs business objectives.
-
EDUCATION:
BSc Human Biology, University of Surrey, UK
Chartered ScientistASSOCIATION MEMBERSHIPS:
FTOPRA, Fellow of The Organisation of Professionals in Regulatory Affairs -
PROFESSIONAL EXPERTISE:
Consultancy Experience:
2024 Co-CEO (EU) Head of Development Eliquent Life Sciences Ltd
2018 – 2023 Co-CEO, Head of Development RApport Global Strategic Services Ltd
2003- 2018 Founder RApport Strategic Services Ltd
1996 – 2003 Independent Regulatory consultantIndustry Experience in Regulatory Affairs:
1991 – 1996 Procter and Gamble Pharmaceuticals Ltd
1987 – 1991 Astra (now AZ) Pharmaceuticals Ltd
1984 – 1987 Revlon/Rorer HealthCare UK Ltd